Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...
Blue Shield of California is one of 17 major health plans that has committed to adopting payment models inspired by the Medicare Innovation Center’s ACCESS Model.
Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.
Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.
Though I have treated thousands of patients since, Nov. 6, 2022 — the day of a record hot New York City Marathon — still ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results